Form 4 for MRNA Moderna
Accepted 2026-09-03 16:50:13 ET · period of report 2026-09-01 · accession 0001682852-26-000163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-03 16:50 | 2026-09-01 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +9,283 | 1.49M | +0.6% | — |
| D | 2026-09-03 16:50 | 2026-09-01 | MRNA | Hoge Stephen | Pres | F - Tax | $140.34 | -4,489 | 1.49M | -0.3% | -$630.0K |
| D | 2026-09-03 16:50 | 2026-09-01 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -9,283 | 92.8K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | M | A | 9,283 | — | 1,494,188 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-09-01 | F | D | 4,489 | $140.34 | 1,489,699 | D | — | — | (F2) Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2026-09-01 | M | D | 9,283 | $0.00 | 92,828 | D | — · — to — | 9,283 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. (F4) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |